German Insurers Want End To Free Pricing In Amnog Review
Drug Prices Are Claimed To Be ‘Out Of Control’
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
You may also be interested in...
The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.
Canada has announced new restrictions on exports to help mitigate the impact of measures in the US to lower medicine prices there.
In the wake of the COVID-19 pandemic and the ensuing economic fallout, pharmaceutical companies could face a range of measures designed to cut government spending on medicines. From relaxing intellectual property rights to delaying reimbursement, In Vivo examines what might be in store for industry.